JP4976307B2 - 新規な抗ウイルス性および免疫刺激性の医薬組成物 - Google Patents

新規な抗ウイルス性および免疫刺激性の医薬組成物 Download PDF

Info

Publication number
JP4976307B2
JP4976307B2 JP2007543938A JP2007543938A JP4976307B2 JP 4976307 B2 JP4976307 B2 JP 4976307B2 JP 2007543938 A JP2007543938 A JP 2007543938A JP 2007543938 A JP2007543938 A JP 2007543938A JP 4976307 B2 JP4976307 B2 JP 4976307B2
Authority
JP
Japan
Prior art keywords
weight
amount
polyunsaturated fatty
selenium
immunostimulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007543938A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008521877A (ja
JP2008521877A5 (enExample
Inventor
イェノェ・シルベレキ
アンドレア・イェドナーコヴィッツ
エルノェネー・コルタイ
デューラ・オルバーン
カタリン・ビーロー
Original Assignee
シンネクス・ミュサキ・フェイレステー・エーシュ・タナーチャドー・コルラートルト・フェレレーシェシェーギュー・タールシャシャーグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シンネクス・ミュサキ・フェイレステー・エーシュ・タナーチャドー・コルラートルト・フェレレーシェシェーギュー・タールシャシャーグ filed Critical シンネクス・ミュサキ・フェイレステー・エーシュ・タナーチャドー・コルラートルト・フェレレーシェシェーギュー・タールシャシャーグ
Publication of JP2008521877A publication Critical patent/JP2008521877A/ja
Publication of JP2008521877A5 publication Critical patent/JP2008521877A5/ja
Application granted granted Critical
Publication of JP4976307B2 publication Critical patent/JP4976307B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007543938A 2004-12-03 2005-11-15 新規な抗ウイルス性および免疫刺激性の医薬組成物 Expired - Fee Related JP4976307B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0402490A HU227588B1 (hu) 2004-12-03 2004-12-03 Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
HUP0402490 2004-12-03
PCT/HU2005/000122 WO2006059169A2 (en) 2004-12-03 2005-11-15 Antiviral and immunostimulating marine fish oil composition

Publications (3)

Publication Number Publication Date
JP2008521877A JP2008521877A (ja) 2008-06-26
JP2008521877A5 JP2008521877A5 (enExample) 2009-05-28
JP4976307B2 true JP4976307B2 (ja) 2012-07-18

Family

ID=89985663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007543938A Expired - Fee Related JP4976307B2 (ja) 2004-12-03 2005-11-15 新規な抗ウイルス性および免疫刺激性の医薬組成物

Country Status (13)

Country Link
US (1) US9381213B2 (enExample)
EP (1) EP1830861B1 (enExample)
JP (1) JP4976307B2 (enExample)
KR (1) KR101263963B1 (enExample)
CN (1) CN101068540B (enExample)
AT (1) ATE429236T1 (enExample)
CA (1) CA2588195C (enExample)
DE (1) DE602005014142D1 (enExample)
DK (1) DK1830861T3 (enExample)
ES (1) ES2326091T3 (enExample)
HU (1) HU227588B1 (enExample)
PL (1) PL1830861T3 (enExample)
WO (1) WO2006059169A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1800675T4 (pl) 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
SMT201800047T1 (it) * 2009-04-29 2018-03-08 Amarin Pharmaceuticals Ie Ltd Composizione farmaceutica stabile e metodi di utilizzo della stessa
JP5710150B2 (ja) * 2010-04-08 2015-04-30 持田製薬株式会社 潜伏性感染疾患の再発抑制剤
JP2012149000A (ja) * 2011-01-18 2012-08-09 Junsei Educational Institution 免疫賦活剤ならびにこれを含む食品および医薬組成物
EP3248467A1 (de) * 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
US20220175850A1 (en) * 2019-04-01 2022-06-09 Houn Simon Hsia Compositions and methods for cancer therapy
US11872252B2 (en) * 2020-08-10 2024-01-16 Houn Simon Hsia Compositions and methods for treating viral infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209973B (en) 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
HU199775B (en) 1988-03-09 1990-03-28 Nagy Peter Literati Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
EP0891771A1 (en) * 1997-07-08 1999-01-20 Health Now, Inc. Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases
CA2313024C (en) * 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil
AT412758B (de) * 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
EP1487431B1 (en) * 2002-03-08 2012-05-02 PhilERA New Zealand Limited Preventing and/or treating cardiovascular disease and/or associated heart failure

Also Published As

Publication number Publication date
KR20070086689A (ko) 2007-08-27
US20080131519A1 (en) 2008-06-05
EP1830861A2 (en) 2007-09-12
CN101068540B (zh) 2013-01-09
DE602005014142D1 (de) 2009-06-04
JP2008521877A (ja) 2008-06-26
CN101068540A (zh) 2007-11-07
EP1830861B1 (en) 2009-04-22
PL1830861T3 (pl) 2009-09-30
HU0402490D0 (en) 2005-02-28
HUP0402490A2 (en) 2009-04-28
WO2006059169A3 (en) 2007-02-22
DK1830861T3 (da) 2009-07-27
KR101263963B1 (ko) 2013-05-13
ATE429236T1 (de) 2009-05-15
CA2588195A1 (en) 2006-06-08
CA2588195C (en) 2014-12-23
ES2326091T3 (es) 2009-09-30
WO2006059169A2 (en) 2006-06-08
HU227588B1 (hu) 2011-09-28
US9381213B2 (en) 2016-07-05

Similar Documents

Publication Publication Date Title
CA1334576C (en) Antiviral pharmaceutical compositions and process for preparing same
US6255347B1 (en) Methods and compositions comprising R-ibuprofen
JP4700808B2 (ja) フルボ酸、および種々の状態の処置におけるその使用
EP0346451A1 (en) Antiviral activity of fatty acids and monoglycerides
JPS6144844B2 (enExample)
JPH02501743A (ja) ウイルス疾患のホスファチジル処置
JP4976307B2 (ja) 新規な抗ウイルス性および免疫刺激性の医薬組成物
WO2020234884A1 (en) Modified black soldier fly larvae oil with modified lauric acid for treatment against biofilm formation and microorganism growth
RU2527347C1 (ru) Стабильная жидкая фармацевтическая композиция комплекса 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцината, обладающая антигипоксическим, антиоксидантным и адаптогенным действием
FI93949B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten suolayhdisteiden valmistamiseksi
JP2008521877A5 (enExample)
KR100718030B1 (ko) 변형성 관절증 치료제
EP0301474A3 (en) New cysteine derivatives having expectorant activity
HK1113910A (en) Antiviral and immunostimulating marine fish oil composition
US4192896A (en) Method of using dialkylphenols in the treatment of mycoplasma diseases
Audit et al. Possible involvement of an acylation mechanism in thalidomide‐induced teratogenesis of the newt (Pleurodeles waltl.)
JP2598726B2 (ja) 動物細胞培養用添加剤
JPH072661A (ja) ミエロパーオキシデース分泌阻害剤
JPH05148140A (ja) マラリア治療薬
NO892195L (no) Fosfatidylbehandling av virussykdom.
FR2682597A1 (fr) Trimethyl-6,10,14-pentadecatriene-5-9,13-one-2-(e,e) pour son application en tant que substance therapeutiquement active.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081114

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081114

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090410

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120123

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120327

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120412

R150 Certificate of patent or registration of utility model

Ref document number: 4976307

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150420

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees